Immunocore Holdings IMCR
NASDAQ IMCR
$32.38 +0.65 (+2.05%)
At close: Nov 10, 2026 · 4:00 PM EST

Immunocore Holdings (IMCR) Other financing activities (as filed) (2021 - 2024)

Updated

Immunocore Holdings (IMCR) reported Other financing activities of $13.36 million for FY2024.

Analysis

Immunocore Holdings (IMCR) Other financing activities (as filed) (2021 - 2024) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at $2 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Immunocore Holdings 1.63 Bn -1.86 Bn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.06 Mn
Jun 30, 2024 -1.12 Mn
Mar 31, 2024 -12.24 Mn
Dec 31, 2022 -1.11 Mn
Sep 30, 2022 -1.42 Mn
Dec 31, 2021 -935,519.36
API Access

Immunocore Holdings Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IMCR&period=max&api_key=YOUR_API_KEY